Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 19
196
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Ent-trachylobane-3β-hydroperoxide, a new diterpene from the root bark of Chrozophora oblongifolia (Fam.; Euphorbiaceae)

ORCID Icon, , , , , & show all
Pages 3177-3184 | Received 15 Sep 2019, Accepted 26 Oct 2019, Published online: 06 Nov 2019
 

Abstract

New ent-trachylobane-3β-hydroperoxide (5) together with four known compounds, ricinine (1), trimethoxy ellagic acid (2), dimethoxy ellagic acid (3) and aleurotolic acid (4) were isolated from the methylene chloride fraction of the root bark of Chrozophora oblongifolia. The structures of these secondary metabolites were elucidated by using different spectroscopic techniques, 1H NMR, 13C NMR, HSQC, HMBC, 1H-1H COSY, NOESY, HR-ESI-MS, EI-MS and comparison with published data. Ent-trachylobane-3β-hydroperoxide showed moderate cytotoxic activity by MTT assay method against human breast cancer cells (MCF-7) and human hepatocyte-derived carcinoma cells (Huh-7) with IC50 values of 24.53 and 34.13 µM, in comparison with IC50 values of 23.47 µM and 15.82 µM for 5-fluorouracil respectively.

Acknowledgements

We would like to acknowledge the department of Agro-Environmental Sciences, Faculty of Agriculture, Kyushu University, Fukuoka, Japan, for carrying out the spectroscopic analysis and cytotoxicity study. The authors also would like to thanks to Mr. Hossam El-Feky, a pharmacist in Egyptian ambulance Authority in South Sinai for his great efforts in collecting the plant material, which is the base for this work.

Disclosure statement

The authors declare that they don't have any conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.